NCT02629224View on ClinicalTrials.gov

ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Patients With Impaired Renal Function and Haemodialysis
Interventions
DRUG

ASP8825

Oral

Trial Locations (2)

Unknown

Fukuoka

Tokyo

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY